Mariam Muwafaq Jasim Albadry
University of Babylon-College of Science for Women-Department of Biology, Iraq
Abeer Fawzi Murad
University of Babylon-College of Science for Women-Department of Biology, Iraq
Mohammad Al Hattab
University of Babylon-College of Science for Women-Department of Biology, Iraq
Background: Dermatophytosis is a widespread superficial fungal infection primarily caused by Trichophyton species and is a significant public health issue, especially in the developing world. The development of decreased susceptibility to certain antifungal drugs has spurred the exploration of natural sources of alternative therapies. Objective: The aim of the study was to examine the epidemiology of dermatophytosis and to compare the antifungal effects of propolis against clinical strains of Trichophyton against standard anti-fungal medications. Methods: 100 clinical samples were taken from patients suspected of dermatophytosis. Sixty-eight (68) samples (68%) were positive for dermatophytes, and 50 isolates were morphologically identified as Trichophyton species by Sabouraud Dextrose Agar culture, macroscopic colony characteristics, and microscopic observation. Results: The most frequent clinical manifestation was that of Tinea corporis (45%), Tinea capitis (21.7%). Among the people in rural areas and those aged 1-24 years, there was more infection. Concentration-dependent antifungal activity on Trichophyton isolates was demonstrated by Propolis, and increasing concentrations of the antifungal increased the degree of inhibition. Out of conventional antifungals, terbinafine was found to have high inhibitory properties, whereas itraconazole in powder form possessed weak or no inhibitory effect under the conditions of the experiment. These results favor propolis as a bioactive natural product. Conclusion: Propolis showed encouraging anti-fungal in vitro effects and could present a prospective natural alternative or complement of dermatophytosis treatment.